Five-year retrospective analysis of treatment efficacy effectiveness of sacubitril/valsartan in heart failure with reduced ejection fraction with end-stage renal disease

被引：0
|
作者：
Hsiao, B. [1 ]
Lin, W. Y. [2 ]
Shao, Y. H. [2 ]
Huang, C. Y. [1 ]
机构：
[1] Taipei Med Univ Hosp, Cardiovasc, Taipei, Taiwan
[2] Taipei Med Univ Hosp, Taipei, Taiwan
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [1] Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end-stage of renal disease
    Lee, Seonhwa
    Oh, Jaewon
    Kim, Hyoeun
    Ha, Jaehyung
    Chun, Kyeong-hyeon
    Lee, Chan Joo
    Park, Sungha
    Lee, Sang-Hak
    Kang, Seok-Min
    ESC HEART FAILURE, 2020, 7 (03): : 1125 - 1129
  • [2] Efficacy and safety of sacubitril-valsartan in heart failure with reduced ejection fraction in end-stage renal patients
    Rascon Sabido, R. Rafael
    Rodriguez Cesar, Santos
    Escobar Gerardo, Baca
    Padron Lucio, San Juan
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 193 - 193
  • [3] Effect of Sacubitril/Valsartan in Patients with Concomitant Heart Failure with Reduced Ejection Fraction and End-Stage Renal Disease on Hemodialysis
    Ahn, Yuran
    Jung, Mi-Hyang
    Youn, Jong-Chan
    Cho, Dong-Hyuk
    Choi, Jimi
    Yoo, Byung-Su
    CIRCULATION, 2024, 150
  • [4] Long-Term Outcomes of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction and Coexisting End-Stage Renal Disease
    Lin, Wan-Ying
    Shao, Yu-Hsuan Joni
    Chiang, Andy F.
    Huang, Chih-Chieh
    Chiang, Kim F.
    Chan, Chao-Shun
    Huang, Chun-Yao
    Hsiao, Bu-Yuan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (02) : 471 - 477
  • [5] Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    McMurray, John J. V.
    Trueman, David
    Hancock, Elizabeth
    Cowie, Martin R.
    Briggs, Andrew
    Taylor, Matthew
    Mumby-Croft, Juliet
    Woodcock, Fionn
    Lacey, Michael
    Haroun, Rola
    Deschaseaux, Celine
    HEART, 2018, 104 (12) : 1006 - 1013
  • [6] Sacubitril/valsartan in heart failure and end-stage renal insufficiency
    Heyse, Alex
    Manhaeghe, Lynn
    Mahieu, Elien
    Vanfraechem, Celine
    Van Durme, Frederik
    ESC HEART FAILURE, 2019, 6 (06): : 1331 - 1333
  • [7] THE COST EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN KOREA
    Lee, J.
    Ko, S.
    VALUE IN HEALTH, 2017, 20 (09) : A617 - A618
  • [8] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION IN SINGAPORE
    Declan, L.
    Tang, Z. X.
    Ng, C.
    Tan, J.
    Trueman, D.
    Woodcock, F.
    Cristino, J.
    VALUE IN HEALTH, 2018, 21 : S106 - S106
  • [9] Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
    Mohebi, Reza
    Liu, Yuxi
    Felker, G. Michael
    Prescott, Margaret F.
    Ward, Jonathan H.
    Pina, Ileana L.
    Butler, Javed
    Solomon, Scott D.
    Januzzi, James L.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (12) : 1673 - 1682
  • [10] Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States
    Zueger, Patrick M.
    Kumar, Varun M.
    Harrington, Rachel L.
    Rigoni, Gianna C.
    Atwood, Alicia
    DiDomenico, Robert J.
    Touchette, Daniel R.
    PHARMACOTHERAPY, 2018, 38 (05): : 520 - 530
12345